Covalent Partners’s Cinemark Holdings CNK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Sell
25,000
-59,500
-70% -$1.52M 4.06% 14
2025
Q4
$1.96M Sell
84,500
-2,500
-3% -$65.7K 8.68% 2
2025
Q3
$2.44M Buy
87,000
+10,000
+13% +$276K 9.18% 3
2025
Q2
$2.32M Sell
77,000
-45,000
-37% -$1.36M 5.59% 3
2025
Q1
$3.04M Buy
122,000
+52,000
+74% +$1.45M 15.02% 3
2024
Q4
$2.17M Sell
70,000
-15,000
-18% -$464K 7.94% 2
2024
Q3
$2.37M Sell
85,000
-50,000
-37% -$1.27M 20.08% 2
2024
Q2
$2.92M Buy
135,000
+10,000
+8% +$181K 39.05% 1
2024
Q1
$2.25M Buy
125,000
+65,000
+108% +$1.02M 17.2% 2
2023
Q4
$845K Sell
60,000
-40,000
-40% -$622K 3.69% 8
2023
Q3
$1.83M Buy
+100,000
New +$1.67M 5.87% 5

Other funds holding CNK

Covalent Partners's CNK Position: Q1 2026 in Review

Covalent Partners reduced its Cinemark Holdings (CNK) stake by 70% in Q1 2026, selling an estimated $1.52M and leaving 25,000 shares worth $713K. The position accounts for 4.06% of the portfolio, ranked #14.

Covalent Partners first reported a position in CNK in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.04M in Q1 2025. 275 funds tracked by Wall St. Rank hold CNK as of Q1 2026.

  • Covalent Partners held 25,000 shares of Cinemark Holdings worth $713K as of Q1 2026.
  • Covalent Partners sold 59,500 Cinemark Holdings shares in Q1 2026, an estimated $1.52M.
  • Cinemark Holdings made up 4.06% of Covalent Partners's portfolio in Q1 2026, its #14 holding.
  • Covalent Partners first reported a position in Cinemark Holdings in Q3 2023 and has held it in 11 quarters since.
  • Covalent Partners's Cinemark Holdings position peaked at $3.04M in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Cinemark Holdings as of Q1 2026.

Based on Covalent Partners's 13F filing for Q1 2026, filed 15 May 2026.